PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[wgg2]

I have been acquiring plx for the past couple of years. I have invested in biotechs for many years. Sideyboy, agree with your analysis and understanding of management's game plan. This is the perfect time to be patient; late phase three trial and in discussions with the FDA. Wow!

Some observations to share: (1)Very interesting article in fabry disease news.com:3/20/19 fabry disease more common than previously thought, experts say. WORTH A READ. If this disease is as prevalent as these exports suggest that bodes very well for prx-102 once a month treatment. (2) If their game plan works out over the next year I hope they can go-it-alone on the phase phase 2b and 3 trials for oprx-106. The uc market for a a pill form of treatment is huge. (3) The market value for Fold is 3.1 billion; and their fabry treatment only applies to about 40% of fabry patients. If prx-102 can help far more fabry patients we have a whole lot of upside ahead.
I look forward to management's update next Monday.